ClinicalTrials.Veeva

Menu

Effects of Oral Collagen Drinks on Human Skin

T

TCI

Status

Enrolling

Conditions

Skin Condition
Collagen Synthesis

Treatments

Dietary Supplement: MAXI Collagen Drink
Dietary Supplement: Collagen Drink
Dietary Supplement: MAXI Collagen Drink_High dose

Study type

Interventional

Funder types

Industry

Identifiers

NCT07605871
SECCR2025-254

Details and patient eligibility

About

The objective of this study is to evaluate the effect of oral collagen drink and MAXI collagen drink on human skin condition improvement.

Full description

This study is a single-center, double-blinded, parallel human trial designed to evaluate the skin beauty effect of oral collagen drink and MAXI collagen drink.

Healthy adult participants aged 18-60 years will be enrolled. Participants will be informed to consume test samples daily for 4 consecutive weeks. Skin measurement and self-assessment questionnaires will be conducted at baseline (before intake), after 1 week, and 4 weeks of consumption.

Enrollment

99 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy Chinese subjects aged 18 to 60 years, both male and female.
  • Wrinkle Severity: Crow's feet graded 2-4; under-eye fine lines graded 2-5; nasolabial folds graded 1-3.
  • Presence of facial skin laxity and sagging.
  • Ability to undergo skin examinations and pre-treatment in the designated test areas.
  • Ability to understand the trial process, participate voluntarily, and sign a written Informed Consent Form (ICF).

Exclusion criteria

  • Pregnant or lactating women, or those planning to become pregnant in the near future.
  • Highly sensitive constitution, history of allergic diseases, or history of allergies to cosmetics.
  • Presence of skin diseases (e.g., psoriasis, eczema, atopic dermatitis, severe acne) or other chronic systemic diseases.
  • Skin conditions in the test area such as birthmarks, hyperpigmentation, inflammation, scars, nevi (moles), or hypertrichosis (excessive hair).
  • Use of anti-inflammatory drugs (e.g., oral or topical corticosteroids) within the past month.
  • Use of cosmetics or other products with similar efficacy within the past 2 weeks.
  • Participation in other human clinical trials for cosmetics within the past month.
  • Any other conditions deemed unsuitable for participation based on clinical assessment.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

99 participants in 3 patient groups

Collagen Drink
Active Comparator group
Description:
oral intake 5 g collagen daily
Treatment:
Dietary Supplement: Collagen Drink
MAXI Collagen Drink
Experimental group
Description:
oral intake 15 mL MAXI collagen daily (equivalent to 5 g of deep hydrolyzed collagen net weight)
Treatment:
Dietary Supplement: MAXI Collagen Drink
MAXI Collagen Drink_High dose
Experimental group
Description:
oral intake 30 mL MAXI collagen daily (equivalent to 10 g of deep hydrolyzed collagen net weight)
Treatment:
Dietary Supplement: MAXI Collagen Drink_High dose

Trial contacts and locations

1

Loading...

Central trial contact

Ping Lin

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems